HCM - Company ID 0001648257
HUTCHMED (China) Ltd trades as HCM and has a market capitalization of $2.08 B, making it the #2101 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $548.51M, down 13.0% from the prior year and net income of $456.91M. This page tracks HUTCHMED (China) Ltd through 589 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-05-29
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years HUTCHMED (China) Ltd's revenue grew from $216.08M to $548.51M, a compound annual growth rate of 10.9%. Net profit margin expanded from 5.4% to 83.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-22 |
| 6-K | - | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-13 |
| 6-K | - | 2026-05-12 |
The largest companies sharing HUTCHMED (China) Ltd's SEC industry classification (pharmaceutical preparations).
HUTCHMED (China) Ltd (HCM) has a market capitalization of $2.08 B as of 2026-05-29, ranking #2101 among US-listed companies.
HUTCHMED (China) Ltd reported revenue of $548.51M for fiscal year 2025, a decrease of 13.0% year over year.
Yes. HUTCHMED (China) Ltd reported net income of $456.91M in its latest fiscal year.